Your browser doesn't support javascript.
loading
Efficacy and safety of anlotinib in patients with advanced malignancy: a single-center, single-arm, phase 2 trial.
Chi, Yihebali; Ji, Guangqian; Zhang, Jing; Tang, Haijian; Yang, Yang; Liu, Wei; Wang, Nan; Gao, Chunhui; Sun, Yongkun; Wang, Jinwan.
Afiliação
  • Chi Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China. yihebalichi@hotmail.com.
  • Ji G; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • Zhang J; Department of Medical Oncology, Sanhuan Cancer Hospital, Chaoyang District, Beijing, China.
  • Tang H; Department of Medical Oncology, The First Affiliated Hospital of Hebei North University, Zhangjiakou, 075000, China.
  • Yang Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • Liu W; Department of Medical Oncology, Sanhuan Cancer Hospital, Chaoyang District, Beijing, China.
  • Wang N; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • Gao C; Department of Medical Oncology, Sanhuan Cancer Hospital, Chaoyang District, Beijing, China.
  • Sun Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • Wang J; Department of Medical Oncology, Sanhuan Cancer Hospital, Chaoyang District, Beijing, China.
Int J Clin Oncol ; 26(9): 1611-1618, 2021 Sep.
Article em En | MEDLINE | ID: mdl-34297245

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China